Strategic Transformation 2023

Strategic Framework (From the 2023 J.P. Morgan Healthcare Conference) Drive reni-cel (EDIT-301) toward BLA and Commercialization editas Platform MEDICINE Strengthen and Focus Discovery to Build in vivo Editing Pipeline Commercial Stage CH Increase Business Development Activities and Monetize IP Long-Term Vision: A Leader in In Vivo Programmable Gene Editing 4

View entire presentation